Further delineation of FKBP14-related Ehlers-Danlos syndrome: A patient with early vascular complications and non-progressive kyphoscoliosis, and literature review

Am J Med Genet A. 2016 Aug;170(8):2031-8. doi: 10.1002/ajmg.a.37728. Epub 2016 May 5.

Abstract

FKBP14-related Ehlers-Danlos syndrome (EDS) is an extremely rare recessive connective tissue disorder described for the first time in 2012 by Baumann and coworkers. The causal gene, FKBP14, encodes a member of the F506-binding family of peptidyl-prolyl cis-trans isomerases. The paucity of patients described so far makes this disorder poorly defined at clinical level. Here, we report an additional pediatric patient, who is compound heterozygous for a recurrent and a novel FKBP14 mutation, and compare his phenotype with those available in literature. This evaluation confirms that kyphoscoliosis (either progressive or non-progressive), myopathy, joint hypermobility, and congenital hearing loss (sensorineural, conductive, or mixed) are the typical features of the syndrome. Since the patient showed a severe cardiovascular event in childhood and atlantoaxial instability, this report expands the phenotype of the disorder and the allelic repertoire of FKBP14. © 2016 Wiley Periodicals, Inc.

Keywords: Ehlers-Danlos syndrome; FKBP14; atlantoaxial instability; joint hypermobility; kyphoscoliosis; vascular complications.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Child
  • DNA Mutational Analysis
  • Ehlers-Danlos Syndrome / diagnosis*
  • Ehlers-Danlos Syndrome / genetics*
  • Exons
  • Facies
  • Genetic Association Studies*
  • Heterozygote
  • Humans
  • Kyphosis / diagnosis
  • Kyphosis / genetics
  • Male
  • Mutation
  • Peptidylprolyl Isomerase / genetics*
  • Phenotype*
  • Radiography
  • Scoliosis / diagnosis
  • Scoliosis / genetics

Substances

  • FKBP14 protein, human
  • Peptidylprolyl Isomerase